Trevena Inc logo

Trevena Inc

FRA:6T4 (USA)  
€ 3.83 (0%) Dec 20
At Loss
Market Cap:
€ 1.30M ($ 1.35M)
Enterprise V:
€ 24.41M ($ 25.41M)
Volume:
-
Avg Vol (2M):
-
Trade In:

Business Description

Description
Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.
Name Current Vs Industry Vs History
Cash-To-Debt 0.36
Equity-to-Asset -1.22
Debt-to-Equity -1.61
Debt-to-EBITDA -1.22
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -48.93
Distress
Grey
Safe
Beneish M-Score -7.56
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
9-Day RSI 41.25
14-Day RSI 40.32
6-1 Month Momentum % -25.73
12-1 Month Momentum % -74.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.42
Quick Ratio 2.42
Cash Ratio 2.21
Days Inventory 207.24
Days Sales Outstanding 119.66
Days Payable 378.58

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -39.3
Shareholder Yield % -836.72
Name Current Vs Industry Vs History
Gross Margin % -190.48
Operating Margin % -5880.04
Net Margin % -6233.7
FCF Margin % -4976.8
ROA % -107.03
ROIC % -476.27
ROC (Joel Greenblatt) % -674.08
ROCE % -122.46

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 2.97
EV-to-EBIT -0.82
EV-to-EBITDA -0.83
EV-to-Revenue 46.63
EV-to-Forward-Revenue 8.39
EV-to-FCF -0.94
Earnings Yield (Greenblatt) % -121.95
FCF Yield % -1742.19

Financials (Next Earnings Date:2025-04-01 Est.)

FRA:6T4's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Trevena Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 0.5
EPS (TTM) (€) -44.836
Beta -0.41
Volatility % 52.27
14-Day RSI 40.32
14-Day ATR (€) 0.000199
20-Day SMA (€) 3.825
12-1 Month Momentum % -74.33
52-Week Range (€) 3.615 - 16.15
Shares Outstanding (Mil) 0.86

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Trevena Inc Filings

Filing Date Document Date Form
No Filing Data

Trevena Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Trevena Inc Frequently Asked Questions

What is Trevena Inc(FRA:6T4)'s stock price today?
The current price of FRA:6T4 is €3.83. The 52 week high of FRA:6T4 is €16.15 and 52 week low is €3.62.
When is next earnings date of Trevena Inc(FRA:6T4)?
The next earnings date of Trevena Inc(FRA:6T4) is 2025-04-01 Est..
Does Trevena Inc(FRA:6T4) pay dividends? If so, how much?
Trevena Inc(FRA:6T4) does not pay dividend.

Press Release

Subject Date
No Press Release